Edition:
United Kingdom

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

36.40USD
12 Dec 2017
Change (% chg)

$0.48 (+1.34%)
Prev Close
$35.92
Open
$35.92
Day's High
$36.74
Day's Low
$35.66
Volume
177,214
Avg. Vol
136,045
52-wk High
$40.35
52-wk Low
$23.07

Select another date:

Tue, Nov 14 2017

BRIEF-Acceleron ‍expects to initiate a phase 2 trial in 1H 2018​

* Acceleron announces preclinical results in pulmonary arterial hypertension at the American Heart Association 2017 Scientific Sessions

BRIEF-Acceleron Pharma qtrly net loss per share $0.65

* Acceleron Pharma reports third quarter 2017 operational and financial results

BRIEF-Acceleron announces pricing of public offering of common stock

* Acceleron announces pricing of public offering of common stock

BRIEF-Acceleron announces proposed public offering of common stock

* Acceleron announces proposed public offering of common stock

BRIEF-Acceleron Pharma Q2 loss per share $0.77

* Acceleron Pharma reports second quarter 2017 operational and financial results

BRIEF-Acceleron announces first patient treated in phase 2 clinical trial of ACE-083

* Acceleron announces first patient treated in phase 2 clinical trial of ACE-083 in Charcot-Marie-Tooth disease Source text for Eikon: Further company coverage:

Select another date: